On the surface of the tumor cells, programmed death ligand 1 (PD-L1) is normally upregulated, allowing them to interact with the programmed death 1 (PD-1) on the surface of the T cells that induce suppression of immune response upon the PD-L1/PD-1 binding. Here, CD274 is linked to neoplasm.